Visual Training for Improving Intermittent Exotropia Visual Function
Clinical Study on the Effectiveness and Safety of Visual Training for Improving Intermittent Exotropia Visual Function
1 other identifier
interventional
78
0 countries
N/A
Brief Summary
The goal of this clinical tral is to investigate that if VR/AR visual training can improve the visual function in children with intermittent exotropia. The main question it aims to answer is : Does the VR/AR visual training can enhance stereoscopic vision function in children with intermittent exotropia. Researchers will compare intervention group to control group to see if VR/AR visual training could enhance stereoscopic vision function in children with intermittent exotropia. Participants will: The intervention group will receive 20 minutes of VR/AR visual training once a day for a period of one year. Follow up check ups at the hospital every 3 months. Keep a diary of the values of stereoscopic vision function and Newcastle Control Score.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2024
CompletedStudy Start
First participant enrolled
September 15, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedSeptember 19, 2024
September 1, 2024
1.2 years
September 10, 2024
September 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
changes in stereoscopic vision function after 6 month
Compare whether the intervention group has better stereoscopic vision function than the control group after 6 months
6 months after baseline
changes in stereoscopic vision function after 12 month
Stop the intervention group training after 6 months and observe for another 6 months to see if there will be a decrease in stereoscopic vision function.
12 month after baseline
Study Arms (2)
VR/AR visual training group
EXPERIMENTALWear glasses for correction combined with VR/AR visual training in the first 6 months, and terminate the training for follow-up observation in the last 6 months. Regular follow-up every 3 months, with a total follow-up time of 1 year.
control group
NO INTERVENTIONNo intervention, simply wearing glasses for correction, followed up every 3 months for a total of 12 months.
Interventions
Wear glasses for correction combined with VR/AR visual training in the first 6 months, and terminate the training for follow-up observation in the last 6 months. Regular follow-up every 3 months, with a total follow-up time of 1 year.
Eligibility Criteria
You may qualify if:
- Aged 6 to 14 years. Intermittent exotropia meeting all of the following criteria: Exodeviation at least 10Δ at distance measured by the prism and alternate cover test, near deviation does not exceed distance deviation by more than 10Δby prism and alternate cover test, mean distance Newcastle Control Score (NCS)≥2 points (mean of 3 assessments during the examination).
- Refractive error between -5.00 D \< spherical equivalents (SEs) ≤ -1.00 D, astigmatism ≤1.50D, anisometropia ≤1.5D, best visual acuity in each eye of 1.0.
- Not receiving any other form of strabismus or myopia treatment within 3 months. Willing to follow the research plan and participate in the entire research process.
- Participants and guardians agree to be randomly assigned and sign an informed consent form.
You may not qualify if:
- Vertical strabismus; Diagnosed with other eye diseases or visual abnormalities such as strabismus, amblyopia, etc; Existence of cognitive or learning disabilities that may affect the effectiveness of training; patients with neurological disorders; Unable to cooperate with eye examination and follow-up work.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2024
First Posted
September 19, 2024
Study Start
September 15, 2024
Primary Completion
November 30, 2025
Study Completion
February 28, 2026
Last Updated
September 19, 2024
Record last verified: 2024-09